ETrade Capital Management’s Medifast MED Stock Holding History

ETrade Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$312K	Sell	1,896 -382	-17%	-$62.9K	0.01%	712
2020 Q2	$316K	Buy	+2,278	New	+$209K	0.01%	646
2020 Q1	–	Sell	-2,475	Closed	-$271K	–	819
2019 Q4	$271K	Sell	2,475 -358	-13%	-$34.6K	0.01%	701
2019 Q3	$294K	Buy	+2,833	New	+$304K	0.01%	682
2018 Q4	–	Sell	-2,258	Closed	-$500K	–	781
2018 Q3	$500K	Buy	2,258 +170	+8%	+$34.5K	0.01%	549
2018 Q2	$334K	Buy	+2,088	New	+$267K	0.01%	618

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

ETrade Capital Management's MED Position: Q3 2020 in Review

ETrade Capital Management reduced its Medifast (MED) stake by 17% in Q3 2020, selling an estimated $62.9K and leaving 1,896 shares worth $312K. The position accounts for 0.01% of the portfolio, ranked #712.

ETrade Capital Management first reported a position in MED in Q2 2018 and has held it in 6 quarters since. The position peaked at $500K in Q3 2018. 240 funds tracked by Wall St. Rank hold MED as of Q3 2020.

ETrade Capital Management held 1,896 shares of Medifast worth $312K as of Q3 2020.
ETrade Capital Management sold 382 Medifast shares in Q3 2020, an estimated $62.9K.
Medifast made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #712 holding.
ETrade Capital Management first reported a position in Medifast in Q2 2018 and has held it in 6 quarters since.
ETrade Capital Management's Medifast position peaked at $500K in Q3 2018.
240 funds tracked by Wall St. Rank held Medifast as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.